News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
834,613 Results
Type
Article (78571)
Company Profile (647)
Press Release (755375)
Multimedia
Podcasts (152)
Webinars (21)
Section
Business (229292)
Career Advice (3790)
Deals (39393)
Drug Delivery (132)
Drug Development (89727)
Employer Resources (200)
FDA (18059)
Job Trends (17218)
News (390577)
Policy (39169)
Tag
Academia (3001)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (111)
Alliances (56501)
ALS (126)
Alzheimer's disease (1624)
Antibody-drug conjugate (ADC) (196)
Approvals (18034)
Artificial intelligence (392)
Autoimmune disease (38)
Automation (22)
Bankruptcy (404)
Best Places to Work (12632)
BIOSECURE Act (22)
Biosimilars (141)
Biotechnology (441)
Bladder cancer (110)
Brain cancer (44)
Breast cancer (414)
Cancer (3317)
Cardiovascular disease (267)
Career advice (3233)
Career pathing (34)
CAR-T (219)
CDC (43)
Cell therapy (598)
Cervical cancer (27)
Clinical research (73551)
Collaboration (1201)
Company closure (4)
Compensation (804)
Complete response letters (44)
COVID-19 (2923)
CRISPR (71)
C-suite (428)
Cystic fibrosis (127)
Data (3394)
Decentralized trials (2)
Denatured (54)
Depression (85)
Diabetes (393)
Diagnostics (7011)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (176)
Drug pricing (165)
Drug shortages (36)
Duchenne muscular dystrophy (172)
Earnings (96468)
Editorial (51)
Employer branding (25)
Employer resources (169)
Events (130954)
Executive appointments (936)
FDA (20144)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1062)
Gene editing (154)
Generative AI (36)
Gene therapy (477)
GLP-1 (972)
Government (5290)
Grass and pollen (7)
Guidances (325)
Healthcare (20909)
HIV (46)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (199)
Immuno-oncology (17)
Indications (43)
Infectious disease (3130)
Inflammatory bowel disease (171)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (144)
Interviews (742)
IPO (17829)
IRA (59)
Job creations (5036)
Job search strategy (2633)
Kidney cancer (14)
Labor market (64)
Layoffs (610)
Leadership (28)
Legal (10011)
Liver cancer (88)
Longevity (12)
Lung cancer (462)
Lymphoma (235)
Machine learning (15)
Management (65)
Manufacturing (500)
MASH (112)
Medical device (14774)
Medtech (14786)
Mergers & acquisitions (22345)
Metabolic disorders (1014)
Multiple sclerosis (108)
NASH (23)
Neurodegenerative disease (167)
Neuropsychiatric disorders (48)
Neuroscience (2449)
NextGen: Class of 2025 (7646)
Non-profit (5094)
Now hiring (52)
Obesity (511)
Opinion (300)
Ovarian cancer (109)
Pain (137)
Pancreatic cancer (139)
Parkinson's disease (207)
Partnered (25)
Patents (357)
Patient recruitment (219)
Peanut (55)
People (65062)
Pharmaceutical (133)
Pharmacy benefit managers (25)
Phase I (22697)
Phase II (32033)
Phase III (24157)
Pipeline (2284)
Policy (268)
Postmarket research (3333)
Preclinical (10120)
Press Release (72)
Prostate cancer (160)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (566)
Real estate (7247)
Recruiting (76)
Regulatory (26918)
Reports (64)
Research institute (2664)
Resumes & cover letters (591)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (113)
Series A (178)
Series B (128)
Service/supplier (27)
Sickle cell disease (71)
Special edition (23)
Spinal muscular atrophy (167)
Sponsored (38)
Startups (4239)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (79)
The Weekly (96)
Vaccines (967)
Venture capital (62)
Weight loss (351)
Women's health (52)
Worklife (20)
Date
Today (105)
Last 7 days (551)
Last 30 days (2735)
Last 365 days (33417)
2025 (21128)
2024 (37924)
2023 (42567)
2022 (53928)
2021 (58722)
2020 (57665)
2019 (51316)
2018 (39101)
2017 (36910)
2016 (37910)
2015 (43948)
2014 (38807)
2013 (35033)
2012 (36980)
2011 (37018)
2010 (36887)
Location
Africa (1213)
Alabama (73)
Alaska (7)
Arizona (270)
Arkansas (14)
Asia (49570)
Australia (8527)
California (8422)
Canada (2570)
China (773)
Colorado (361)
Connecticut (377)
Delaware (227)
Europe (112519)
Florida (1265)
Georgia (290)
Hawaii (3)
Idaho (66)
Illinois (755)
India (36)
Indiana (407)
Iowa (19)
Japan (252)
Kansas (119)
Kentucky (34)
Louisiana (20)
Maine (75)
Maryland (1172)
Massachusetts (6391)
Michigan (285)
Minnesota (520)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (94)
New Hampshire (75)
New Jersey (2340)
New Mexico (31)
New York (2320)
North Carolina (1300)
North Dakota (10)
Northern California (3706)
Ohio (268)
Oklahoma (17)
Oregon (46)
Pennsylvania (1792)
Puerto Rico (18)
Rhode Island (42)
South America (1589)
South Carolina (40)
South Dakota (1)
Southern California (3164)
Tennessee (136)
Texas (1305)
United States (31482)
Utah (250)
Virginia (227)
Washington D.C. (81)
Washington State (722)
West Virginia (4)
Wisconsin (88)
834,613 Results for "medical and biological laboratories co ltd mbl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
August 12, 2025
·
6 min read
Sponsored
Taipei City Government Partners With Six Biotech Companies to Showcase at BIO International Convention 2025
The 2025 BIO International Convention (BIO2025), the world’s largest annual biotech event, will take place from June 16 to 19 (U.S. time) at the Boston Convention & Exhibition Center. This year, Taipei City Government is partnering with six Taipei-based biotech companies, including PanCAD.ai Co., Ltd., Instant NanoBiosensors Co., Ltd., Bened Biomedical Co., Ltd., Cancer Free Biotech Ltd., Xantho Biotechnology Co., Ltd., and Energenesis Biomedical Co., Ltd., to showcase their innovations at the Taiwan Pavilion (Booth #1645) in the Taipei Exhibition Area.
June 16, 2025
·
5 min read
Press Releases
WORK Medical Technology Group LTD Announces Strategic Partnership with Shanghai Chartwell Medical Device Co., Ltd.
March 3, 2025
·
5 min read
BioMidwest
AriBio Co., Ltd. Announces Strategic Collaboration with Kentucky Clinical Trial Laboratory (KCTL) to Expand Alzheimer’s Disease Testing
AriBio Co., Ltd. announces the expansion of testing for Alzheimer’s disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory for the testing of cerebral spinal fluid to accurately and efficiently aid in the diagnosis of Alzheimer’s disease using the Lumipulse® system from FujireBio.
June 21, 2024
·
3 min read
Press Releases
Medicus Pharma Ltd. to Present at BTIG Virtual Biotech Conference 2025
Executive Chairman & CEO of the Company to Participate in a Fireside Chat
July 21, 2025
·
6 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Closing of $4.8 Million Initial Public Offering
December 31, 2024
·
4 min read
Press Releases
Univar Solutions and Shandong Head Group Co., Ltd. Establish Exclusive European Partnership to Enhance Supply of Cellulose Ethers and Pharmaceutical Excipients
May 22, 2025
·
7 min read
Press Releases
Park Ha Biological Technology Co., Ltd. Announces Pricing of $4.8 Million Initial Public Offering
December 26, 2024
·
4 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August 2025
August 5, 2025
·
2 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
1 of 83,462
Next
